KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Invested Capital: 2017-2024

Historic Invested Capital for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to -$15.2 million.

  • Aquestive Therapeutics' Invested Capital rose 628.10% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 628.10%. This contributed to the annual value of -$15.2 million for FY2024, which is 75.35% up from last year.
  • Latest data reveals that Aquestive Therapeutics reported Invested Capital of -$15.2 million as of FY2024, which was up 75.35% from -$61.5 million recorded in FY2023.
  • Aquestive Therapeutics' Invested Capital's 5-year high stood at -$15.2 million during FY2024, with a 5-year trough of -$80.1 million in FY2021.
  • In the last 3 years, Aquestive Therapeutics' Invested Capital had a median value of -$61.5 million in 2023 and averaged -$47.9 million.
  • In the last 5 years, Aquestive Therapeutics' Invested Capital plummeted by 650.11% in 2020 and then skyrocketed by 75.35% in 2024.
  • Yearly analysis of 5 years shows Aquestive Therapeutics' Invested Capital stood at -$45.9 million in 2020, then slumped by 74.45% to -$80.1 million in 2021, then climbed by 16.30% to -$67.1 million in 2022, then increased by 8.30% to -$61.5 million in 2023, then skyrocketed by 75.35% to -$15.2 million in 2024.